Moldrug algorithm for an automated ligand binding site exploration by 3D aware molecular enumerations
We present Moldrug, a computational tool for accelerating the hit-to-lead phase in structure-based drug design. Moldrug explores the chemical space using structural modifications suggested by the CReM library and by optimizing an adaptable fitness function with a genetic algorithm. Moldrug is complemented by Moldrug-Dashboard, a cross-platform and user-friendly graphical interface tailored for the analysis of Moldrug simulations. To illustrate Moldrug, we designed new potential inhibitors targeting the main protease (M<sup>Pro</sup>) of SARS-CoV-2 by optimizing a consensus fitness function that balances binding affinity, drug-likeness, and synthetic accessibility. The designed molecules exhibited high chemical diversity. A subset of the designed molecules were ranked using MM/GBSA and alchemical binding free energy calculations, revealing predicted affinities as low as <mml:math xmlns:mml="http://www.w3.org/1998/Math/MathML"><mml:mrow><mml:mo>-</mml:mo> <mml:mn>10</mml:mn> <mml:mspace></mml:mspace> <mml:mspace></mml:mspace> <mml:mtext>kcal</mml:mtext> <mml:mspace></mml:mspace> <mml:msup><mml:mtext>mol</mml:mtext> <mml:mrow><mml:mo>-</mml:mo> <mml:mn>1</mml:mn></mml:mrow> </mml:msup> </mml:mrow> </mml:math> . Moldrug is distributed as a Python package under the Apache 2.0 license. It offers pre-configured multi-parameter fitness functions for molecular design, while being highly adaptable for integrating functionalities from external software. Documentation and tutorials are available at https://moldrug.rtfd.io .
Authors
- Alejandro Martínez León
- Jochen S. Hub (ORCID: https://orcid.org/0000-0001-7716-1767)
- Benjamin Ries (ORCID: https://orcid.org/0000-0002-0945-8304)
- Aniket Magarkar (ORCID: https://orcid.org/0000-0003-3385-964X)
Institutions
- Boehringer Ingelheim (Germany) (DE)
- Open Geospatial Consortium (US)
- Saarland University (DE)
Publication Details
- Journal
- Journal of Cheminformatics
- Published
- 2025-05-26
- DOI
- https://doi.org/10.1186/s13321-025-01022-3
- Primary Topic
- Computational Drug Discovery Methods
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- European Commission
- Deutsche Forschungsgemeinschaft